Literature DB >> 30386610

The XL probe: A luxury or a necessity? Risk stratification in an obese community cohort using transient elastography.

Rebecca Harris1, Timothy R Card2, Toby Delahooke3, Guruprasad P Aithal1,4, I Neil Guha1,4.   

Abstract

BACKGROUND: Transient elastography is a non-invasive tool which can stratify patients at risk of chronic liver disease. However, a raised body mass index has been independently associated with a failed or unreliable examination.
OBJECTIVE: The purpose of this study was to analyse the performance of two probes (M/XL) on a portable transient elastography device within an obese community population.
METHOD: The method involved a prospective study with recruitment from a primary care practice. Patients identified with a risk factor for chronic liver disease were invited to a community-based risk stratification pathway for transient elastography readings with both probes. A threshold of ≥8.0 kPa defined elevated liver stiffness.
RESULTS: A total of 477 patients attended the pathway. Of the patients, 21% had no valid measurements with the M probe. There was a significant difference between the probes in the proportion achieving ≥10 valid readings (M versus XL probe: 66.2% versus 90.2%; p ≤ 0.001) and in their reliability (M versus XL probe: 77.4% versus 98.5%; p = 0.028). Unreliable readings with the M probe increased as the body mass index increased. The XL probe re-stratified 5.2% of patients to have a normal reading.
CONCLUSION: The XL probe on a portable device significantly improves the applicability of transient elastography within a community-based risk stratification pathway.

Entities:  

Keywords:  Transient elastography; chronic liver disease; community; obesity; risk stratification

Year:  2018        PMID: 30386610      PMCID: PMC6206541          DOI: 10.1177/2050640618772944

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  25 in total

1.  Outreach screening of drug users for cirrhosis with transient elastography.

Authors:  Belinda K Moessner; Tina R Jørgensen; Merete Skamling; Mogens Vyberg; Peter Junker; Court Pedersen; Peer B Christensen
Journal:  Addiction       Date:  2010-12-23       Impact factor: 6.526

Review 2.  An appraisal of the histopathological assessment of liver fibrosis.

Authors:  R A Standish; E Cholongitas; A Dhillon; A K Burroughs; A P Dhillon
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

3.  Factors associated with significant liver fibrosis assessed using transient elastography in general population.

Authors:  Seng Chan You; Kwang Joon Kim; Seung Up Kim; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Won Jae Lee; Kwang-Hyub Han
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

4.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

5.  Determination of reliability criteria for liver stiffness evaluation by transient elastography.

Authors:  Jérôme Boursier; Jean-Pierre Zarski; Victor de Ledinghen; Marie-Christine Rousselet; Nathalie Sturm; Brigitte Lebail; Isabelle Fouchard-Hubert; Yves Gallois; Frédéric Oberti; Sandrine Bertrais; Paul Calès
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

6.  Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations.

Authors:  Juliette Foucher; Laurent Castéra; Pierre-Henri Bernard; Xavier Adhoute; David Laharie; Julien Bertet; Patrice Couzigou; Victor de Lédinghen
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-04       Impact factor: 2.566

7.  Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease.

Authors:  Raj Vuppalanchi; Mohammad S Siddiqui; Mark L Van Natta; Erin Hallinan; Danielle Brandman; Kris Kowdley; Brent A Neuschwander-Tetri; Rohit Loomba; Srinivas Dasarathy; Manal Abdelmalek; Edward Doo; James A Tonascia; David E Kleiner; Arun J Sanyal; Naga Chalasani
Journal:  Hepatology       Date:  2017-11-29       Impact factor: 17.425

8.  The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Elliot B Tapper; Tracy Challies; Imad Nasser; Nezam H Afdhal; Michelle Lai
Journal:  Am J Gastroenterol       Date:  2016-03-15       Impact factor: 10.864

9.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

10.  Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography.

Authors:  David J Harman; Stephen D Ryder; Martin W James; Matthew Jelpke; Dominic S Ottey; Emilie A Wilkes; Timothy R Card; Guruprasad P Aithal; Indra Neil Guha
Journal:  BMJ Open       Date:  2015-05-03       Impact factor: 2.692

View more
  2 in total

1.  Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation.

Authors:  Holly Knight; David Harman; Joanne R Morling; Guruprasad Aithal; Timothy Card; Indra Neil Guha; Manpreet Bains
Journal:  BMJ Open       Date:  2020-11-18       Impact factor: 2.692

2.  Embedding assessment of liver fibrosis into routine diabetic review in primary care.

Authors:  Dina Mansour; Allison Grapes; Marc Herscovitz; Paul Cassidy; Jonathan Vernazza; Andrea Broad; Quentin M Anstee; Stuart McPherson
Journal:  JHEP Rep       Date:  2021-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.